# Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Male Subjects

> **NCT04636983** · PHASE1 · COMPLETED · sponsor: **BioVersys SAS** · enrollment: 54 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** BV100
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04636983
- **Lead sponsor:** BioVersys SAS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-09
- **Primary completion:** 2021-12-12
- **Final completion:** 2022-01-20
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2022-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04636983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04636983, "Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Male Subjects". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04636983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*